ERNA
Ernexa Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.37
−3.53%Leverage
- Debt / equity
- 0.11x
- Net debt / equity
- -1.46x
- Debt / assets
- 0.06x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.27x
Liquidity & coverage
- Current ratio
- 2.01x
- Quick ratio
- 2.01x
- Cash ratio
- 1.71x
- Interest coverage
- -378.61x
- EBITDA / interest
- -563.32x
- Working capital
- $3.0M
Cash & dividend
- FCF / debt
- -25.44x
- Cash flow / debt
- -25.32x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026